Ed Schutter has over thirty years of pharmaceutical industry experience and served as President of Sciele (Shionogi) Pharmaceuticals prior to joining Arbor. Prior to his Sciele experience, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles in commercial operations at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, Ga. Ed has a degree in Pharmaceutical Sciences from Mercer University and an MBA from Kennesaw State University. He serves on the board of Knight Therapeutics (GUD.TO), Vensun Pharmaceuticals, Establishment Labs, Mercer University and GA BIO.